Roam Robotics entered into a partnership with the San Francisco VA healthcare system to study the impact of its wearable robots on the veteran population

2021-12-13 16:29:07 By : Mr. Songlin Xi

Ascend from Roam Robotics uses robotics and proprietary algorithms to improve the mobility of patients with knee pain and significantly improve their daily lives

San Francisco, December 7, 2021/PRNewswire/ - Roam Robotics, a company leading the expansion of human mobility through wearable robotics, today announced the San Francisco VA Healthcare System (SFVAHCS) and the Northern California Institute and Education (NCIRE) ) Has begun to recruit patients to study the impact of Ascend on the veteran population, which is a first-of-its-kind smart brace.

Ascend from Roam Robotics is a smart knee orthosis designed to relieve knee pain and intuitively support daily activities. Previous clinical studies of knee osteoarthritis participants showed that after using the device, pain was reduced by an average of 46%, and 67% of people showed functional improvement. Ascend is the first wearable robotic device that is useful in daily life for people with knee pain, who want to regain independence and lead a more active lifestyle. Ascend is also registered as a Class I medical device by the FDA.

"I am very happy to be able to evaluate Roam Robotics' Ascend powered knee pads on veterans with knee osteoarthritis, who experience considerable knee pain during daily activities," said Dr. Alfred Kuo, Director of Orthopedic Surgery at VA Health in San Francisco. System "The rate of veterans suffering from knee arthritis and other musculoskeletal diseases is higher than that of the general population. For many of these patients, especially those with moderate disease, we do not have good treatment options. The Ascend branch has the potential to be significant. To improve pain, stability and function."

Ascend provides a non-opioid and non-surgical solution to relieve pain and increase stability while performing common exercises such as walking, kneeling, standing, sitting, and up and down steps. Sujit Dike, Vice President of Roam Robotics, said: "Roam's technology has previously been proven to be beneficial for all kinds of patients suffering from knee pain, quadriceps weakness or instability. "We have this partnership with San Francisco VA. The relationship is very excited. It can further verify the potential impact of Roam technology in solving the huge and growing challenges faced by the veteran population".

Tim Swift, CEO and founder of Roam, said: “Roam focuses on large-scale markets with low service levels. More than 20% of the world’s population is limited by physical activity. As medical advances help people live longer, this number is only It will increase.". "Our wearable robotic approach works seamlessly with the human body to help people live healthier, happier, and more active lives without being affected by physical limitations."

Roam Robotics is committed to helping millions of people transcend their current physical boundaries and expand their ability to engage in activities they love. Roam was founded by Dr. Tim Swift in 2013. He dreams of developing lightweight, low-cost, wearable robotic devices that can be easily integrated into daily life. Roam's proprietary technology produces an unparalleled power-to-weight ratio, using scalable manufacturing technology and using innovative wearable robotics technology to improve and extend the boundaries of human mobility.

For more information about Ascend, please visit: www.ascend.health For more information about Roam Robotics, please visit: www.roamrobotics.com

Follow Roam Robotics on LinkedIn and Twitter.

View original content and download multimedia: https://www.prnewswire.com/news-releases/roam-robotics-launches-partnership-with-the-san-francisco-va-health-care-system-to-study-the- impact-of-its-robotic-wearable-on-the-veteran-population-301439548.html

Both companies currently play a secondary role in front of the leaders in the coronavirus vaccine market.

Adding this unique healthcare group to your investment portfolio now may generate substantial dividend income in the future.

Nigerian students hope to change the rules of the game in the medical industry through his eye-catching bold illustrations.

A Bucks County biopharmaceutical company dedicated to the treatment of chronic hepatitis B has reached a licensing and cooperation agreement with a Chinese pharmaceutical company valued at up to 300 million U.S. dollars. According to the terms of the agreement, Jinan Qilu Pharmaceutical will obtain the exclusive rights of Arbutus Biopharma's main new drug candidate for the treatment or prevention of hepatitis B, AB-729, in Mainland China, Hong Kong, Macau and Taiwan. In return, Warminster’s Arbutus (NASDAQ: ABUS) will receive an upfront payment of US$40 million, up to US$245 million in development and commercialization milestone payments, double-digit tiered royalties, and 15 million Equity investment in US dollars. Arbutus CEO William Collier called Qilu an "ideal partner" because the company has extensive development, regulatory and commercialization capabilities in China.

Musk is also the founder and CEO of SpaceX and leads the brain chip startup Neuralink and the infrastructure company The Boring Company. Tesla produces hundreds of thousands of cars every year and avoids supply chain issues better than many competitors. At the same time, it has prompted many young consumers to switch to electric vehicles and traditional automakers to shift their focus to electric vehicles. "In order to solve the existential crisis, reflect the possibilities and dangers of the era of technology giants, and promote the boldest and most destructive changes in society, Elon Musk was named the 2021 Person of the Year by Time magazine," the editor-in-chief of the magazine, Edward Felsenthal said. "Even Elon Musk's space adventure comes directly from Charles Lindbergh, the first person of the year, who was selected by the editor in 1927 to commemorate his historic first solo transatlantic flight across the Atlantic."

Karen Jubanyik, MD, emergency physician at Yale University School of Medicine, associate professor at Yale University School of Medicine, co-author of "Overcoming Coronavirus: Strategies to Stay Safe and Deal with the New Normal During the COVID-19 Pandemic", tells us how to not catch up COVID. "All of us must act together and act in the best interest of our community," she said. "If we don't act decisively and swiftly, worse variants are likely to emerge." Continue reading her 5 ways to save lives

YouTube blogger and bodybuilder Will Tennyson broke his exercise and eating habits after losing 20 pounds in the last month.

Today, the public, legislators, and scientists are reassessing the long-term reputation of cannabis—for better or for worse. Public recognition of recreational marijuana use has never been higher, and record-breaking 19 states have now legalized recreational use. Increasing acceptance has prompted researchers to carefully study the side effects of cannabis. A new study found that cannabis can have unexpected and potentially dangerous effects on your daily life. Keep reading to learn more and ens

It is believed that the man was paid for trying to deceive people in the system.

The EDM star died in 2018 when he was only 28 years old.

You and Diet Dr Pepper are like peanut butter and jelly. Without Mountain Dew, you will not be able to pass the 4pm meeting. Watching a movie in the cinema, without a cold Cherry, I can’t stand it...

According to the United Health Foundation's 2021 American Health Ranking Annual Report, the early impact of COVID-19 on the health and well-being of Americans is complex and subtle. That report...

"I messed up all my relationships. It cost me too much, and it's definitely not worth it." View entire post ›

Alzheimer's disease is the most common dementia in the United States, affecting more than 5 million people. At the same time, it seems extra mysterious. Although scientists are increasingly certain about the cause of Alzheimer's disease—including the accumulation of toxic plaques called amyloid in the brain—there is still a lot of knowledge about the disease, including how the brain responds. Respond to the progression of the disease (and therefore how to slow it down or stop). But a recent study provided

With the legalization of marijuana nationwide, more and more people are addicted to marijuana consumption. And there are good reasons. As we all know, they can help treat the poor...

Although COVID-19 is fading in the United States, Americans are paying attention to a different epidemic that shows no signs of abating: obesity. More Americans than ever before—about 42% of people—are eligible for clinical obesity. Considering that obesity can significantly increase the risk of serious diseases such as heart disease, diabetes, cancer and dementia, this is an urgent problem. But solutions are available, and they must first recognize the main causes of obesity. The following is what the experts say. Read on to learn more

Winter is here, and as the number of COVID cases in certain states and regions continues to increase, there may be a surge. Taking certain precautions, such as vaccinations, wearing masks, social distancing and washing hands does help, but it is still possible to catch COVID. The virus affects each person slightly differently, but there are some common symptoms that require attention, and sometimes they may occur in a certain pattern. Eat this, not that! Health talked with experts, they explained the symptoms and sequence to pay attention to

Due to the overcrowding of hospitals, mixed information and over-selling of highly effective vaccines, many people are confused about getting COVID boosters.

When talking about vaccine regulations, Abbott said: "It depends on whether someone puts something in their body that they don't want to put in their body." "That's not just freedom."

According to general practitioner David Lloyd (David Lloyd), 15% of local children infected with omicron have spots on their bodies. Is the vaccine effective for omicron?